Author:
Gorkin Larry,Kantarjian Hagop
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. NOVARTIS. Novartis Q4 and FY 2015 condensed financial report. [online] , (2016).
2. REUTERS. Sun hopes cut-price generic Gleevec will win third of U.S. market. [online] , (2016).
3. Padula, W. V. et al. Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in chronic phase after generic entry of imatinib in the United States. J. Natl Cancer Inst. 108, djw003 (2016).
4. Chhatwal, J., Mathisen, M. & Kantarjian, H. Are high drug prices for hematologic malignancies justified? A critical analysis. Cancer 121, 3372–3379 (2015).
5. Institute for Clinical and Economic Review. Evaluating the value of new drugs. [online] , (2015).
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献